Impact of prior breast cancer on mode of delivery and pregnancy-associated disorders: a retrospective analysis of subsequent pregnancy outcomes

2017 ◽  
Vol 143 (6) ◽  
pp. 1069-1074 ◽  
Author(s):  
Louis Jacob ◽  
Matthias Kalder ◽  
Birgit Arabin ◽  
Karel Kostev
2019 ◽  
Vol 220 (1) ◽  
pp. S212-S213
Author(s):  
Andrea Desai ◽  
Nicole Krenitsky ◽  
Audrey A. Merriam ◽  
Katherine Kohari ◽  
Christian Pettker ◽  
...  

2021 ◽  
Vol 0 (0) ◽  
pp. 0-0
Author(s):  
Xiaoxu Chen ◽  
Jinsong Gao ◽  
Juntao Liu ◽  
Jing Hu ◽  
Sijian Li ◽  
...  

2021 ◽  
Vol 8 (8) ◽  
pp. 442-447
Author(s):  
Antigoni Sarantaki ◽  
Kyriaki Perisaki

Objective: Breast cancer is the most common cancer type in women of reproductive age. Given that most women postpone childbearing, breast cancer occurrence possibly perplexes their plans for starting a family. The treatment for breast cancer can affect their fertility and have adverse effects on a pregnancy that occurs during that period. The aim of this narrative review is primarily to explore the influence of breast cancer therapy on the ability of a woman diagnosed with breast cancer to gestate. Moreover, to determine the safer timing for childbearing after being treated for breast cancer and investigate the pregnancy outcome when conception is succeeded. Childbearing after treatment for breast cancer is considered safe and pregnancy outcomes are favorable if conception happens 1 year after chemotherapy or at least 2 years after chemotherapy and radiation therapy. Counseling is of great significance and fertility preservation methods should be thoroughly discussed with women diagnosed with breast cancer, even prior to commencement of the treatment


2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Béatrice Eggel ◽  
Maude Bernasconi ◽  
Thibaud Quibel ◽  
Antje Horsch ◽  
Yvan Vial ◽  
...  

AbstractIn this case control study, long-term gynecological, reproductive and sexual outcomes after uterine artery embolization (UAE) for postpartum hemorrhage (PPH) were evaluated. The study was performed in a single referral hospital for PPH in Lausanne from 2003 to 2013. Each woman whose delivery was complicated by PPH and treated by UAE was included, and compared to a control group of women whose delivery was uncomplicated. Cases were matched by maternal age, parity, ethnicity, year and mode of delivery, birth weight and gestational age in a 1–3 ratio. A total of 77 patients treated by UAE for PPH were identified in our obstetrical database. Among them, 63 were included and compared to 189 matched patients (no PPH). The mean interval time between UAE and this study was 8.1 years. Time to menstrual cycle recovery after delivery (3.9 vs 5.6 months, p = 0.66), spotting (7.9% vs 7.2%, p = 0.49), dysmenorrhea (25.4% vs 22.2%, p = 0.60) and amenorrhea (14.3% vs 12.2%, p = 0.66) were similar between the two groups. There was no difference in the FSFI score between the groups (23.2 ± 0.6 vs 23.8 ± 0.4; p = 0.41). However, the interval time to subsequent pregnancy was longer for patients after UAE than the control group (35 vs 18 months, p = 0.002). In case of pregnancy desire, the success rate was lower after UAE compared to controls (55% vs 93.5%, p < 0.001). The rate of PPH was higher in those with previous PPH (6.6% vs 36.4%, p = 0.010). Patients treated by UAE for PPH did not report higher rates of gynecological symptoms or sexual dysfunction compared to patients with uneventful deliveries. The inter-pregnancy interval was increased and the success rate was reduced. In subsequent pregnancies, a higher rate of PPH was observed in those that underwent UAE.


2013 ◽  
Vol 11 ◽  
pp. S79-S83 ◽  
Author(s):  
Francesca Rovera ◽  
Matteo Lavazza ◽  
Stefano La Rosa ◽  
Anna Fachinetti ◽  
Corrado Chiappa ◽  
...  

2018 ◽  
Vol 18 (1) ◽  
pp. e79-e88 ◽  
Author(s):  
Brigitte Gerstl ◽  
Elizabeth Sullivan ◽  
Angela Ives ◽  
Christobel Saunders ◽  
Handan Wand ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document